| Product NDC: | 54531-100 |
| Proprietary Name: | Minocin |
| Non Proprietary Name: | minocycline hydrochloride |
| Active Ingredient(s): | 100 mg/1 & nbsp; minocycline hydrochloride |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 54531-100 |
| Labeler Name: | Rempex Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA050444 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20130419 |
| Package NDC: | 54531-100-01 |
| Package Description: | 10 INJECTION in 1 CARTON (54531-100-01) |
| NDC Code | 54531-100-01 |
| Proprietary Name | Minocin |
| Package Description | 10 INJECTION in 1 CARTON (54531-100-01) |
| Product NDC | 54531-100 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | minocycline hydrochloride |
| Dosage Form Name | INJECTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20130419 |
| Marketing Category Name | NDA |
| Labeler Name | Rempex Pharmaceuticals, Inc. |
| Substance Name | MINOCYCLINE HYDROCHLORIDE |
| Strength Number | 100 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Tetracycline-class Drug [EPC],Tetracyclines [Chemical/Ingredient] |